Last updated at 15 Nov 2025 02:00 PM
Director
DIN: 08061781
Veerareddy Vallapureddy is currently associated with 3 companies in various capacities such as Designated Partner and Director. They serve as a Director at SUNAXA PHARMA LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08061781.Veerareddy Vallapureddy has previously been associated with 2 companies in roles such as Director and Additional Director.Veerareddy Vallapureddy is currently involved in 2 different roles. Their most recent position is with SUNAXA PHARMA PRIVATE LIMITED as a Director. The first company Veerareddy Vallapureddy was appointed to as a director was SUNAXA PHARMA LLP. Veerareddy Vallapureddy is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Veerareddy Vallapureddy is currently associated with 3 companies in various capacities such as Designated Partner and Director. They serve as a Director at SUNAXA PHARMA LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08061781.Veerareddy Vallapureddy has previously been associated with 2 companies in roles such as Director and Additional Director.Veerareddy Vallapureddy is currently involved in 2 different roles. Their most recent position is with SUNAXA PHARMA PRIVATE LIMITED as a Director. The first company Veerareddy Vallapureddy was appointed to as a director was SUNAXA PHARMA LLP. Veerareddy Vallapureddy is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (2)
Past Companies (2)
1y 7m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SUNAXA PHARMA PRIVATE LIMITED | Director | 29-Sep-2025 |